Clinical Trial Update: Study of CAP1-6D in Patients With Locally Advanced or Surgically Resected Pancreatic Adenocarcinoma [Phase 1, Phase 2]

View source ↗

Summary

Results from a Phase 1/2 study of CAP1-6D in patients with locally advanced or surgically resected pancreatic adenocarcinoma are presented. The trial is complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• CAP1-6D

Snippet

Sponsor: University of Chicago | Conditions: Pancreatic Adenocarcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-03-14